The Diagnostic Process and Your Pathology Report
At a Glance
A white patch in the vagina cannot be classified reliably by appearance alone. Colposcopy helps target a biopsy, and the laboratory report determines whether the change is harmless, a low- or high-grade precancerous lesion, or invasive cancer.
While a visual exam can identify a white patch, it cannot tell your care team what the cells are doing beneath the surface. Because the appearance of leukoplakia (a white patch) can be caused by anything from harmless irritation to high-grade precancer, the diagnostic process must move from “looking” to “testing” [1][2].
The Role of Vaginal Colposcopy
Evaluation usually begins with a complete vulvovaginal and speculum examination. As an adjunct to this, a doctor may use a specialized magnifying instrument called a colposcope to look closely at the walls of the vagina [3]. They may apply a vinegar-like solution (acetic acid) or an iodine solution (Lugol’s) to the area to make abnormal cells easier to see [4].
It is important to know that while colposcopy is a vital tool for targeting a biopsy, it is not perfectly accurate on its own. In various studies, doctors’ visual impressions sometimes misidentified high-grade disease or could not distinguish it from benign changes [4][5]. This is why colposcopy is used to guide a biopsy, rather than replace it.
What to Expect During a Biopsy
A colposcopy-directed biopsy—taking a small sample of the tissue for lab analysis—is the most reliable way to establish a diagnosis [2].
- The Procedure: Your doctor will use the colposcope to find the most suspicious part of the white patch and take a tiny piece of it (often the size of a grain of rice).
- Sensation: You may feel a pinch, pressure, or a brief sharp cramping sensation. Some doctors use a local anesthetic to numb the area, though not always.
- Aftercare: You can expect some light spotting or a dark discharge (if a liquid bandage called Monsel’s solution was used) for a few days. Your doctor will likely advise you to avoid tampons, intercourse, and submerging in water until the area heals.
In some cases, a small punch biopsy might not provide enough information. If the lab report states that “invasion cannot be excluded,” it means the pathologist cannot tell for sure if the abnormal cells have started to spread into deeper layers of tissue [2]. This does not automatically mean you have cancer; it simply means a larger procedure called an excisional biopsy (removing the entire patch) may be required to get a definitive answer [6].
Understanding Your Pathology Report
The pathology report is the document that guides your treatment. It translates the white patch into a specific medical diagnosis. To be complete, your report may contain several key data points:
1. The Grade of the Lesion
If the diagnosis is VaIN (changes associated with HPV), it should be graded using two different systems:
- The Binary System: This classifies cells as either vLSIL (Low-grade Squamous Intraepithelial Lesion) or vHSIL (High-grade Squamous Intraepithelial Lesion) [7].
- The Numeric System: This provides more detail, ranking the changes from VaIN 1 (mild viral effect) to VaIN 2 or VaIN 3 (more severe, true precancer) [2].
2. Specialized Staining (Immunohistochemistry)
Pathologists sometimes selectively use special “stains” to help confirm a diagnosis when cells look equivocal under a standard microscope. These are not required on every report.
- p16: This is a protein marker used as a surrogate for high-risk HPV activity. A “strong and diffuse” p16 result often supports a diagnosis of high-grade precancer (vHSIL/VaIN 2-3) when it matches the visual morphology [7].
- Ki-67: This marker shows how fast cells are dividing. While helpful, it is used alongside other findings and is not a stand-alone test [8].
3. Exclusion of Invasive Cancer
One of the most critical parts of the report is assessing whether the abnormal cells have invaded the deeper tissue. If the report mentions stromal invasion, it indicates that the condition has progressed beyond precancer to invasive cancer [2].
Pathology Report Completeness Checklist
You can use this checklist to ensure you and your doctor have all the information needed to move forward. (Note: Not all items are required for every biopsy, but they are useful concepts to ask about.)
| Data Point | Why It Matters |
|---|---|
| Site Identification | Confirms exactly where (vagina vs. vulva) the sample was taken. |
| Specific Diagnosis | Distinguishes between benign changes, inflammatory dermatoses, or VaIN [9]. |
| Specific Grade | Distinguishes between low-grade (vLSIL/VaIN 1) and high-grade (vHSIL/VaIN 2-3) [7]. |
| Invasion Status | Clearly states if invasive cancer was seen or if it “cannot be excluded” [6]. |
| Ancillary Stains | Notes if p16 or other markers were selectively used to confirm the diagnosis [2]. |
If any of these points are missing or unclear, it is a good starting point for a conversation with your healthcare team. You may even request that your slides be reviewed by a specialized gynecologic pathologist for a second opinion if the results are complex or do not match what the doctor saw during the exam [10].
Common questions in this guide
Can a colposcopy alone diagnose a vaginal white patch?
What do VaIN 1, VaIN 2, and VaIN 3 mean?
What do p16 and Ki-67 mean on a vaginal pathology report?
What does “invasion cannot be excluded” mean on my biopsy report?
What does stromal invasion mean in vaginal pathology?
What information should a vaginal leukoplakia pathology report include?
One line in your results can change your plan.
A pathology report saying invasion cannot be excluded may mean a larger excisional biopsy is needed. We check your results against the latest research to help you prepare for what’s next.
Related questions
Get notified when new evidence is published on leukoplakia of vagina.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (10)
- 1
Erosive Lichen Sclerosus-A Clinicopathologic Subtype.
Day T, Otton G, Dennerstein G, et al.
Journal of lower genital tract disease 2021; (25(3)):255-260 doi:10.1097/LGT.0000000000000607.
PMID: 33859124 - 2
The European Society of Gynaecological Oncology (ESGO), the International Society for the Study of Vulvovaginal Disease (ISSVD), the European College for the Study of Vulval Disease (ECSVD), and the European Federation for Colposcopy (EFC) consensus statement on the management of vaginal intraepithelial neoplasia.
Kesic V, Carcopino X, Preti M, et al.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2023; (33(4)):446-461 doi:10.1136/ijgc-2022-004213.
PMID: 36958755 - 3
Abnormal Pap Smear and Diagnosis of High-Grade Vaginal Intraepithelial Neoplasia: A Retrospective Cohort Study.
Sopracordevole F, Mancioli F, Clemente N, et al.
Medicine 2015; (94(42)):e1827 doi:10.1097/MD.0000000000001827.
PMID: 26496321 - 4
Application of 2011 International Federation for Cervical Pathology and Colposcopy Terminology on the Detection of Vaginal Intraepithelial Neoplasia.
Zhou Q, Zhang F, Sui L, et al.
Cancer management and research 2020; (12()):5987-5995 doi:10.2147/CMAR.S257875.
PMID: 32765098 - 5
Screening History in Vaginal Precancer and Cancer: A Retrospective Study of 2131 Cases in China.
Zhang L, Wang Q, Zhang H, et al.
Cancer management and research 2021; (13()):8855-8863 doi:10.2147/CMAR.S335701.
PMID: 34858059 - 6
Vaginal Intraepithelial Neoplasia: Histopathological Upgrading of Lesions and Evidence of Occult Vaginal Cancer.
Sopracordevole F, De Piero G, Clemente N, et al.
Journal of lower genital tract disease 2016; (20(1)):70-4 doi:10.1097/LGT.0000000000000150.
PMID: 26461231 - 7
[Nomenclature of squamous cell precursor lesions of the lower female genital tract : Current aspects].
Horn LC, Brambs CE, Handzel R, et al.
Der Pathologe 2016; (37(6)):526-533 doi:10.1007/s00292-016-0239-8.
PMID: 27738814 - 8
Assessment of CK17 as a Marker for the Diagnosis of Differentiated Vulvar Intraepithelial Neoplasia.
Podoll MB, Singh N, Gilks CB, et al.
International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists 2017; (36(3)):273-280 doi:10.1097/PGP.0000000000000317.
PMID: 27513074 - 9
Clinicopathologic Diagnostic Criteria for Vulvar Lichen Planus.
Day T, Wilkinson E, Rowan D, et al.
Journal of lower genital tract disease 2020; (24(3)):317-329 doi:10.1097/LGT.0000000000000532.
PMID: 32205763 - 10
[Vaginal Follicular dendritic cell sarcoma in patient with previous urinary tract carcinoma. Case Report].
Zaya AM, González AC, Sandrone SS, Sambuelli RH
Revista de la Facultad de Ciencias Medicas (Cordoba, Argentina) 2016; (73(2)):126-31.
PMID: 27420147
This page is for informational purposes only and does not constitute medical advice. Your gynecologist and pathologist can interpret your vaginal biopsy and explain the next steps for your specific situation.